Search results for: 31

Home › You searched for 31 › Page 29

August 31, 2018 0

$93 Million for TraceLink to Further Global Development to Fight Counterfeit Drugs

TraceLink Inc. announced August, 21 that it has closed a $93 million investment round led by Georgian Partners, ...

August 29, 2018 0

How Nathaniel David is Transforming the Healthcare Industry

Nathaniel David is no stranger to the healthcare industry. The scientist and entrepreneur has co-founded a number of ...

August 23, 2018 0

Healthcare Trends: Principia BioPharma Goes Public to Raise Money for New Drug

The clinical-stage biopharmaceutical firm Principia Biopharma, which researches and develops pharmaceutical treatments for inflammatory and autoimmune diseases, has ...

August 21, 2018 0

Entasis Therapeutics Might Help Patients Battling Drug Resistant Bacteria as Early as Next Year

Privately owned Entasis Therapeutics, a company working on new antibacterial drugs to treat drug-resistant bacterial infections, is going ...

August 17, 2018 0

Report: Illinois Has Room For Improvement When It Comes to Pain Policies For Cancer Patients

Illinois is being praised in a new report for increasing access to healthcare through Medicaid and for its ...

August 14, 2018 0

Will Patient Care Improve as GM and Ford Health Sign Innovative Contract?

General Motors is offering a new, lower-cost health insurance option to salaried employees. Called “ConnectedCare,” the new plan ...

August 13, 2018 0

Redefining Physical Exercise as We Know It: 3 things I Learned From Ryan Eder, CEO at IncludeHealth

Despite accounting for 18% of our country’s GDP, the healthcare industry has undergone very few digital innovation initiatives ...

August 11, 2018 0

Howard Buffett Announces $30M Illinois Investment to Fight Drug Addiction

The private foundation of Howard Buffett, eldest son of Berkshire Hathaway’s billionaire CEO, Warren Buffett, plans to invest ...

July 30, 2018 0

Great News for Big Pharma: BenevolentAI Uses New Funds to Prepare ALS Drug Clinical Trials

This spring, an investor-backed British artificial intelligence start-up, BenevolentAI, received $115 million to prepare an ALS drug for ...